Search

everythinglearnresearchcommunity

for

Search:↓

The ayurvedic hair oil is safe and effective for reducing hair fall, promoting hair growth, and improving scalp health.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

New treatments for hair loss, including a compound called "ALRV5XR", platelet-rich plasma, and Adult Stem Cell-based therapy, are showing promise, but more trials are needed for confirmation.

Topical 5% minoxidil is safe and effective for treating hair loss in Korean men.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

5% minoxidil works better for hair growth than 1% minoxidil.

Finasteride 1 mg/day for five years effectively improves hair growth and slows hair loss in men with male pattern baldness, and is safe for long-term use.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

Dutasteride is a safe and effective treatment for hair loss.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.

Platelet-Rich Plasma (PRP) may increase hair density and thickness in Androgenetic Alopecia, but it's not significantly better than a placebo.

Probiotics help reduce hair loss and increase hair growth in people with androgenic alopecia.

Blocking JAK-STAT signaling can lead to hair growth.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

The new treatment was safe and may effectively treat male pattern hair loss.

Setipiprant did not significantly improve hair growth in men with hair loss.

The new baby shampoo and wash with stearic acid is safe and potentially effective for nourishing babies' skin.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

The conclusion is that maintaining blinding in clinical trials is crucial for reliable results.

Melatonin may inhibit melanoma growth and has potential as a cancer therapy aid, but its effects on human skin pigmentation need more research.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.